View Older Stories

Jan 30, 2026 05:41AM Summit Therapeutics (SMMT) Reiterated at Market Outperform by Citizens

Jan 29, 2026 07:30AM FDA accepts Summit Therapeutics BLA for lung cancer drug ivonescimab

Jan 14, 2026 06:54AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)

Jan 13, 2026 04:21AM Summit Therapeutics (SMMT) Reiterated at Market Outperform by Citizens

Jan 12, 2026 06:15AM Summit Therapeutics partners with GSK for cancer drug combination trial

Jan 12, 2026 06:01AM Summit Therapeutics files FDA application for cancer drug ivonescimab

Dec 19, 2025 06:56AM Summit Therapeutics' (SMMT) HARMONi-2 Important 2026 Catalyst - Cantor Fitzgerald

Dec 17, 2025 04:02AM Barclays Upgrades Summit Therapeutics plc (SMMT) to Equalweight

Nov 7, 2025 09:02AM Ivonescimab shows survival benefit in lung cancer study

Oct 31, 2025 07:00AM Summit to present ivonescimab lung cancer trial results at SITC 2025

Oct 30, 2025 04:32AM Summit Therapeutics (SMMT) files for 26.68M share offering by selling stockholders

Oct 21, 2025 06:43AM Summit Therapeutics plc (SMMT) PT Lowered to $40 at H.C. Wainwright

Oct 20, 2025 02:17PM Summit Therapeutics plc (SMMT) PT Lowered to $42 at Jefferies

Oct 20, 2025 09:50AM Citizens Highlights Summit’s (SMMT) Ivonescimab Superiority, Reiterates at Outperform

Oct 20, 2025 09:22AM UBS Reiterates Buy Rating on Summit Therapeutics plc (SMMT)

Oct 20, 2025 07:37AM Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT) After Management Meet

Oct 20, 2025 06:48AM Summit Therapeutics (SMMT) Tops Q3 EPS by 4c

Oct 20, 2025 06:45AM Summit Therapeutics plans to submit BLA for cancer drug in Q4 2025

Oct 17, 2025 07:00AM Summit Therapeutics launches phase III colorectal cancer trial

Oct 10, 2025 09:29AM UBS Reiterates Buy Rating on Summit Therapeutics plc (SMMT)

Oct 4, 2025 04:00PM Why UBS says Q4 is eventful for SMID oncology stocks

Sep 25, 2025 04:14AM Citi Opens 30-Day Upside Catalyst Watch on Summit Therapeutics plc (SMMT)

Sep 24, 2025 07:00AM Summit presents lung cancer trial data at ESMO 2025

Sep 17, 2025 04:36AM Barclays Starts Summit Therapeutics plc (SMMT) at Underweight

Sep 16, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)

Sep 10, 2025 04:18AM Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)

Sep 9, 2025 05:28AM Summit Therapeutics (SMMT) call put ratio 1.9 calls to 1 put amid wide price movement

Sep 8, 2025 07:36AM Akeso reports improved survival data for cancer drug ivonescimab

Sep 8, 2025 07:12AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)

Sep 8, 2025 04:20AM Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)

Sep 3, 2025 04:13PM Guggenheim Starts Summit Therapeutics plc (SMMT) at Buy

Sep 3, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)

Aug 27, 2025 06:36AM Summit Therapeutics plc (SMMT) PT Raised to $50 at H.C. Wainwright, 'Time to own SMMT'

Aug 26, 2025 11:48AM TD Cowen on Summit Therapeutics plc (SMMT): 'Stat Sig Overall Survival In Akeso's HARMONi-A Bodes Well For Summit's HARMONi'

Aug 22, 2025 07:48AM UBS Reiterates Buy Rating on Summit Therapeutics plc (SMMT)

Aug 19, 2025 06:18AM Piper Sandler Starts Summit Therapeutics plc (SMMT) at Neutral

Aug 19, 2025 04:29AM Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)

Aug 12, 2025 05:13AM Summit Therapeutics plc (SMMT) PT Raised to $34 at Evercore ISI

Aug 12, 2025 03:34AM Summit Therapeutics (SMMT) Misses Q2 EPS by 3c

Jul 28, 2025 07:20AM Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT)

Jul 3, 2025 10:17AM Summit Therapeutics (SMMT) Is Said In Talks For $15 Billion Partnership With Astra (AZN) - Bloomberg

Jul 1, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)

Jul 1, 2025 12:49AM UBS Starts Summit Therapeutics plc (SMMT) at Buy

Jun 30, 2025 12:54PM Clear Street Starts Summit Therapeutics plc (SMMT) at Buy

Jun 30, 2025 08:07AM Revolution Medicines (RVMD) and Summit Therapeutics (SMMT) Enter Into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors With Ivonescimab in RAS Mutant Tumors

Jun 24, 2025 06:35AM Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT)

Jun 11, 2025 06:19AM Leerink Partners Starts Summit Therapeutics plc (SMMT) at Underperform

Jun 2, 2025 06:46AM Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT)

Jun 2, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)

Jun 2, 2025 04:07AM Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)

View Older Stories